The Efficacy of italic Ganoderma lucidum in Overweight Individuals: A Randomized Placebo-controlled trial
Mediterranean Journal of Nutrition and Metabolism
; 15(2):263-271, 2022.
Article
in English
| EMBASE | ID: covidwho-2154628
ABSTRACT
BACKGROUND:
There are growing interests in the use of medicinal mushrooms in controlling overweight and obesity. OBJECTIVE(S) The aim of the present study was to assess the effect of Lingzhi on anthropometric indices, fasting blood sugar, lipid profile and blood pressure of overweight individualsMETHODS:
This randomized double-blind clinical trial was performed on seventy-two overweight individuals (Body Mass Index (BMI)?=?25-29.9?kg/m2) received 3 capsule Ganoderma Lucidum (each capsule containing 220?mg of whole powder and 30?mg of pure aqueous extract) daily or matching placebo for 6 weeks. Anthropometric indices, metabolic tests (fasting blood sugar (FBS) and serum lipid profile) and blood pressure were measured before and after treatment. RESULT(S) Data analyses indicated that body weight and BMI were decreased after 6-week intervention (P?<?0.05). The beneficial effect of supplementation was evident on some anthropometric indices. Changes in LDL-cholesterol were significantly different between two treatment and placebo groups (P?<?0.05). FBS, other components of lipid profile and blood pressure did not significantly change by Lingzi treatment. CONCLUSION(S) Results showed that Ganoderma Lucidum might have some potential benefits on anthropometric indices and mild effects on lipid profile, but and there is no claim for weight lose function. Hence, further long-term studies are recommended. Copyright © 2022 - IOS Press. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Experimental Studies
/
Randomized controlled trials
Language:
English
Journal:
Mediterranean Journal of Nutrition and Metabolism
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS